PeptideStack
5.2kquestions
20kanswers
220users

Is vomiting on dulaglutide dose-dependent or dose-rate dependent?

Asked 15 Apr 2025Modified 12 months agoViewed 11k times
19

The case in front of me: vomiting · dulaglutide.

I suspect the usual explanation for this is wrong, or at least incomplete.

I am aware this may have a boring answer. I would still like the boring answer stated clearly.

So what is the mechanism, and how well established is it?

vomiting
vomiting

Emesis as a reported adverse event: trial incidence, its relationship to dose escalation rate, dehydration risk, and when it stops being a…

57 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
dulaglutide
dulaglutide

A once-weekly GLP-1 receptor agonist built on an Fc fusion rather than fatty-acid acylation. Use this tag for questions about the fusion-protein…

200 questions
shareeditfollowflag
LS
askedlukas_sedlacek16k1815 Apr 2025

5 Answers

Sorted by votes
34

Answer first: vomiting is less common than nausea, is more strongly dose-related, and matters chiefly because of what it does to fluid and electrolyte balance.

Trial incidence for vomiting runs at roughly a third to a half of the nausea rate depending on agent and dose, and it is more concentrated in the escalation phase than nausea is.

Local reaction versus infection

FeatureLocal reactionSterile abscessCellulitis
OnsetHours to 2 daysDays1–4 days, progressive
WarmthAbsent or minimalMildMarked
ExpansionStatic or shrinkingSlowExpanding
TextureFirm, flat or raisedFluctuantDiffuse, indurated
Systemic featuresNoneNoneFever, malaise possible
ActionObserve, rotate siteClinical reviewSame-day clinical review

Stated carefully, oral rehydration solutions work by glucose-coupled sodium co-transport, which continues to function when secretion is deranged. That is why the glucose-to-sodium ratio matters and a high-sugar sports drink is not equivalent.

Rinse rather than brush after an episode. Enamel is not replaceable.

shareimprove this answerflag
DB
answeredDr_Ingrid_Baumgartner73k5813 Jun 2025
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
24

The honest answer is that a day of it is unpleasant and that several days of it needs help.

Repeated vomiting is the mechanism behind most reported acute kidney injury in this class. The renal event is a volume event, not a direct toxicity.

Concretely, dental enamel erosion from repeated vomiting is a real if unglamorous consequence; rinsing with water rather than brushing immediately is the standard advice.

Vomiting rates in the trial programmes are reported separately from nausea and are consistently lower and more dose-dependent.

The renal risk here is volume, not toxicity. That is the mechanism to watch.

shareimprove this answerflag
DO
answeredDr_Lena_Ostrowska38k272 Jun 2025
7Worth adding that the area postrema explanation also predicts why it settles. – s_kalniete 9 months ago
8Any published figure for how long the constipation persists, given it does not attenuate? – petra_hovland 13 days ago
add a comment
19

The underlying point is that the relevant risk chain is vomiting to volume depletion to reduced renal perfusion to a rising creatinine, which is how most acute renal events in this class occur.

An episode of vomiting several days after a dose, with no escalation and no other explanation, is not the typical pattern and deserves attention rather than tolerance.

A practical home formulation is about six level teaspoons of sugar and half a level teaspoon of salt in one litre of water, taken in small frequent sips rather than in volumes that provoke another episode.

Oral rehydration solution composition is standardised by the World Health Organization and rests on glucose-coupled sodium transport.

If fluids will not stay down for several hours, that is the threshold. Get help.

shareimprove this answerflag
PT
answeredpascal_thibault11k175 Jul 2025
3Same pattern here, and it resolved on the timeline described. – thermal_mass 2 months ago
add a comment
16

To be exact about it, this is the adverse effect where the honest advice is least about tolerance and most about knowing when to stop.

Warning signs that convert this from a nuisance to a clinical problem: inability to keep fluids down for more than a few hours, reduced urine output, dizziness on standing, confusion, or severe abdominal pain.

Anti-emetics interact with other medication and are a prescriber decision.

Do not escalate the dose while this is happening.

shareimprove this answerflag
DF
answeredDr_Nadia_Farsi104k24724 Jun 2025
10

Start with frequency and duration, because an isolated episode after an escalation and repeated episodes over days are different problems.

Fluid lost in vomit carries sodium at roughly 60 millimoles per litre and potassium at rather less, so replacing it with plain water alone dilutes plasma sodium rather than restoring balance.

Electrolyte composition of gastric and intestinal secretions is published and is the basis for replacement calculations.

Research-use material is not approved for human use, and an unverified dose is an unquantifiable variable in any of this.

Small frequent sips of an oral rehydration solution, not large volumes of water.

shareimprove this answerflag
OF
answeredorla_ferriter89k14827 Jul 2025
3Small correction: the discontinuation rate in the trials is lower than most people assume. – claudia_ferrante 24 days ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.